UK markets closed

Novo Nordisk A/S (0QIU.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
842.40-35.65 (-4.06%)
At close: 07:12PM BST
Currency in DKK

Valuation measures4

Market cap (intra-day) 3.89T
Enterprise value 3.91T
Trailing P/E 44.10
Forward P/E 38.17
PEG ratio (5-yr expected) 2.43
Price/sales (ttm)16.12
Price/book (mrq)39.60
Enterprise value/revenue 16.02
Enterprise value/EBITDA 31.56

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 360.76%
S&P500 52-week change 322.43%
52-week high 3932.00
52-week low 386.66
50-day moving average 3877.97
200-day moving average 3735.42

Share statistics

Avg vol (3-month) 3982.9k
Avg vol (10-day) 3974.46k
Shares outstanding 53.4B
Implied shares outstanding 64.2B
Float 83.21B
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 47.08
Forward annual dividend yield 41.04%
Trailing annual dividend rate 37.07
Trailing annual dividend yield 30.81%
5-year average dividend yield 41.58
Payout ratio 441.65%
Dividend date 3N/A
Ex-dividend date 418 Aug 2023
Last split factor 22:1
Last split date 313 Sept 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 33.40%
Operating margin (ttm)43.20%

Management effectiveness

Return on assets (ttm)21.76%
Return on equity (ttm)81.54%

Income statement

Revenue (ttm)201.33B
Revenue per share (ttm)44.69
Quarterly revenue growth (yoy)31.60%
Gross profit (ttm)148.51B
EBITDA 92.89B
Net income avi to common (ttm)67.24B
Diluted EPS (ttm)14.86
Quarterly earnings growth (yoy)45.90%

Balance sheet

Total cash (mrq)36.41B
Total cash per share (mrq)8.11
Total debt (mrq)25.7B
Total debt/equity (mrq)28.41%
Current ratio (mrq)0.88
Book value per share (mrq)20.18

Cash flow statement

Operating cash flow (ttm)89.73B
Levered free cash flow (ttm)53.32B